Neuroprotective mechanism of bromocriptine - PubMed (original) (raw)

Neuroprotective mechanism of bromocriptine

H Yamashita et al. Lancet. 1995.

No abstract available

PubMed Disclaimer

Comment in

• Neuroprotection in Parkinson's disease.
  Montastruc JL, Rascol O, Senard JM. Montastruc JL, et al. Lancet. 1996 Jan 20;347(8995):196. doi: 10.1016/s0140-6736(96)90381-5. Lancet. 1996. PMID: 8544568 No abstract available.

Similar articles

• Neuroprotection in Parkinson's disease.
  Montastruc JL, Rascol O, Senard JM. Montastruc JL, et al. Lancet. 1996 Jan 20;347(8995):196. doi: 10.1016/s0140-6736(96)90381-5. Lancet. 1996. PMID: 8544568 No abstract available.
• Neuroprotection in PD--a role for dopamine agonists?
  Schapira AH. Schapira AH. Neurology. 2003 Sep 23;61(6 Suppl 3):S34-42. doi: 10.1212/wnl.61.6_suppl_3.s34. Neurology. 2003. PMID: 14504378 Review. No abstract available.
• Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists.
  Kitamura Y, Taniguchi T, Shimohama S, Akaike A, Nomura Y. Kitamura Y, et al. Neurochem Res. 2003 Jul;28(7):1035-40. doi: 10.1023/a:1023207222944. Neurochem Res. 2003. PMID: 12737528
• Newer therapies for Parkinson's disease.
  Korczyn AD, Nisipeanu P. Korczyn AD, et al. Neurol Neurochir Pol. 1996;30 Suppl 2:105-11. Neurol Neurochir Pol. 1996. PMID: 9100248 Review. No abstract available.
• [The role of dopaminagonists in the treatment of Parkinson's disease].
  Ransmayr G. Ransmayr G. Praxis (Bern 1994). 2005 Oct 19;94(42):1633-8. doi: 10.1024/0369-8394.94.42.1633. Praxis (Bern 1994). 2005. PMID: 16277084 German.

Cited by

• The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
  Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, Saeki T, Aihara M, Yoshida H, Mitani A, Tanaka K. Harada T, et al. J Clin Invest. 2007 Jul;117(7):1763-70. doi: 10.1172/JCI30178. J Clin Invest. 2007. PMID: 17607354 Free PMC article.
• Functions of the two glutamate transporters GLAST and GLT-1 in the retina.
  Harada T, Harada C, Watanabe M, Inoue Y, Sakagawa T, Nakayama N, Sasaki S, Okuyama S, Watase K, Wada K, Tanaka K. Harada T, et al. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4663-6. doi: 10.1073/pnas.95.8.4663. Proc Natl Acad Sci U S A. 1998. PMID: 9539795 Free PMC article.
• Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1.
  Mitani A, Tanaka K. Mitani A, et al. J Neurosci. 2003 Aug 6;23(18):7176-82. doi: 10.1523/JNEUROSCI.23-18-07176.2003. J Neurosci. 2003. PMID: 12904478 Free PMC article.
• Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo.
  Harada T, Harada C, Wang YL, Osaka H, Amanai K, Tanaka K, Takizawa S, Setsuie R, Sakurai M, Sato Y, Noda M, Wada K. Harada T, et al. Am J Pathol. 2004 Jan;164(1):59-64. doi: 10.1016/S0002-9440(10)63096-9. Am J Pathol. 2004. PMID: 14695319 Free PMC article.
• Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST.
  Hakuba N, Koga K, Gyo K, Usami SI, Tanaka K. Hakuba N, et al. J Neurosci. 2000 Dec 1;20(23):8750-3. doi: 10.1523/JNEUROSCI.20-23-08750.2000. J Neurosci. 2000. PMID: 11102482 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information